Detailansicht

Wissensnetz

Person

Klaus Herfarth

Arzt

Name	Klaus Herfarth
Ort	Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Klaus K. Herfarth K. Herfarth Klaus Herfarth Klaus Karl-Friedrich Herfarth
Beziehung	Klinikum Heidelberg
Weitere Angaben	Stellvertretender Ärztlicher Direktor der Abteilung Radioonkologie und Strahlentherapie der Radiologischen Klinik Heidelberg
Datensatztyp	Person
GND-Nummer	1032757582
Datensatz-ID	1032757582
Beteiligt an alle anzeigen Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07) Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial Morphologisches Ansprechen bei Radiotherapie indolenter nodaler Lymphome in Kombination mit einer anti-CD20-Antikörpertherapie Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era Radiotherapy in the GHSG HD 16 and HD 17 trials – quality assurance and dosimetric analysis for Hodgkin lymphoma in the modern era Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial Rolle der Radiotherapie beim Hodgkin-Lymphom Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations: an overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO) Retrospektive Vergleichsanalyse der Behandlung von Patienten mit Meningeomen mithilfe von Photonen und Protonen hinsichtlich patientenrelevanter Funktionsparameter und Dosisspezifika unter Strahlentherapie Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT 3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil Definitive Strahlentherapie des Ösophaguskarzinoms mit simultan integriertem Boost : eine retrospektive Analyse Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience Inzidenzen intrazerebraler radiogener Veränderungen nach Protonenbestrahlung und Photonenbestrahlung bei Patienten mit Gehirntumoren Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison Significance of intra-fractional motion for pancreatic patients treated with charged particles Bedeutung der Radioonkologie beim Plasmozytom oder multiplen Myelom Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas Moderne Radiotherapie beim Hodgkin-Lymphom Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC Significance of intra-fractional motion for pancreatic patients treated with charged particles Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons – the APROVE-trial Management of organ motion in scanned ion beam therapy Management of organ motion in scanned ion beam therapy New quality assurance program integrating “modern radiotherapy” within the German Hodgkin Study Group Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison Radiotherapy of indolent orbital lymphomas : Two radiation concepts Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : Four-year outcomes Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial Stereotactic body radiotherapy for liver tumors : Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Klaus Herfarth

Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma

Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)

Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial

Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial

Morphologisches Ansprechen bei Radiotherapie indolenter nodaler Lymphome in Kombination mit einer anti-CD20-Antikörpertherapie

Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era

Radiotherapy in the GHSG HD 16 and HD 17 trials – quality assurance and dosimetric analysis for Hodgkin lymphoma in the modern era

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability

Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial

Rolle der Radiotherapie beim Hodgkin-Lymphom

Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations: an overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO)

Retrospektive Vergleichsanalyse der Behandlung von Patienten mit Meningeomen mithilfe von Photonen und Protonen hinsichtlich patientenrelevanter Funktionsparameter und Dosisspezifika unter Strahlentherapie

Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study

Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer

Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study

Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT

3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial

Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial

Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil

Definitive Strahlentherapie des Ösophaguskarzinoms mit simultan integriertem Boost : eine retrospektive Analyse

Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study

Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial

Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution

Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma

High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience

Inzidenzen intrazerebraler radiogener Veränderungen nach Protonenbestrahlung und Photonenbestrahlung bei Patienten mit Gehirntumoren

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma

Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions

Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study

Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution

Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison

Significance of intra-fractional motion for pancreatic patients treated with charged particles

Bedeutung der Radioonkologie beim Plasmozytom oder multiplen Myelom

Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas

Moderne Radiotherapie beim Hodgkin-Lymphom

Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC

Significance of intra-fractional motion for pancreatic patients treated with charged particles

Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons – the APROVE-trial

Management of organ motion in scanned ion beam therapy

Management of organ motion in scanned ion beam therapy

New quality assurance program integrating “modern radiotherapy” within the German Hodgkin Study Group

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison

Radiotherapy of indolent orbital lymphomas : Two radiation concepts

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial

Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : Four-year outcomes

Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma

Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial

Stereotactic body radiotherapy for liver tumors : Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis

Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas